Keywords: roche, pay, up, million, euros, thrombogenics/bioinvent, cancer

Roche to pay up to 500 million euros for ThromboGenics/BioInvent's cancer Ab

Article | 30 June 2008

Print This

In a second mega-million dollar licensing deal for Switzerland-based drug major Roche in less than a year, the company has ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in